What Sildenafil Orifarm Treats: Main Uses and Benefits

This medication is commonly used across two primary therapeutic domains. It is applied in contexts where additional symptomatic support is needed for conditions presenting with systemic or localized discomfort.

Sildenafil Orifarm is generally used to address Erectile Dysfunction (ED) and is considered relevant support in the management of Pulmonary Arterial Hypertension (PAH). These conditions involve symptoms that create noticeable functional strain, such as the inability to achieve or sustain a functional erection or reduced exercise capacity associated with its condition. Its use supports the management of these symptom clusters and provides supportive relief that helps patients cope more steadily with symptom fluctuations.

“The medication is applied to address associated symptom clusters, and may assist patients with maintaining functional stability when symptoms interfere with routine activities.”

---

Quick Fact: Relief for Functional Impairment

Therapeutic Domain	Symptom Targeted	Primary Benefit
Sexual Health	Inability to attain or sustain a functional erection.	May assist with maintaining functional stability and supports general well-being.
Cardiopulmonary	Reduced capacity for physical activity/fatigue (in PAH).	Helps cope more steadily with chronic symptomatic strain.

---

Regulatory References

1. NIH MedlinePlus overview

Who Can and Cannot Use Sildenafil Orifarm?

Eligibility for Sildenafil Orifarm is strictly defined by regulatory documents, focusing on patient population and specific health conditions. The medicine is primarily indicated for adult men with Erectile Dysfunction and adult patients with Pulmonary Arterial Hypertension (PAH). Pediatric use is limited to those aged 1 to 17 years for the PAH indication only, though chronic use is not recommended in this group due to safety concerns.

---

Absolute Contraindications

The medicine must not be used by patients who fall into the following regulatory-defined groups:

• Patients taking any form of organic nitrates or nitric oxide donors.
• Patients taking riociguat (a guanylate cyclase stimulator).
• Patients with a history of non-arteritic anterior ischaemic optic neuropathy (NAION) or a recent history of stroke or myocardial infarction.
• Patients with severe hepatic impairment (Child-Pugh Class C) or resting hypotension (blood pressure < 90/50 mmHg).

---

Conditional Use and Restrictions

Use is restricted in populations where drug clearance is altered, such as those with severe renal impairment or mild to moderate hepatic impairment, often requiring special consideration. For women, the medicine is not indicated for the ED use, and its safety during pregnancy and lactation has not been established in controlled studies.

Interactions with other medicines and products

Sildenafil Orifarm’s interaction profile is defined by officially documented additive effects on blood pressure (pharmacodynamic) and significant changes in metabolic clearance (pharmacokinetic). All interaction statements are derived from government regulatory labeling.

---

Formal Restrictions and Contraindications

Co-administration is formally contraindicated with Organic Nitrates and Guanylate Cyclase Stimulators (e.g., Riociguat) due to the documented risk of potentiating severe hypotensive effects.

---

Pharmacokinetic Interactions (Exposure Alteration)

The drug's clearance is significantly mediated by the Cytochrome P450 3A4 (CYP3A4) enzyme system. Potent CYP3A4 Inhibitors (such as Ritonavir and Ketoconazole) substantially increase Sildenafil’s systemic exposure (AUC and C max). The official label specifies that with certain inhibitors, the dose must not exceed 25 mg within a 48-hour period. Conversely, CYP3A4 Inducers (like Rifampicin and Bosentan) can cause significant decreases in exposure by accelerating clearance.

---

Pharmacodynamic and Substance Interactions

A pharmacodynamic interaction exists with Alpha-Blockers and other Antihypertensive Agents, leading to an additive blood pressure-lowering effect. Regulatory documents note the risk of symptomatic hypotension is highest within four hours of co-administration. Additionally, Grapefruit juice is documented as potentially causing a modest increase in plasma levels, and heavy alcohol consumption may increase the risk of hypotension. Official labeling also notes that Sildenafil clearance is reduced in patients with severe hepatic or severe renal impairment, resulting in increased systemic exposure.

Selective Inhibition of PDE5 and cGMP Accumulation

Sildenafil Orifarm acts as a selective competitive inhibitor of Phosphodiesterase type 5 (PDE5), an enzyme predominantly present in vascular smooth muscle cells. By blocking PDE5, the drug prevents the breakdown of the second messenger molecule, cyclic Guanosine Monophosphate (cGMP), leading to its localized accumulation within the cell. This interaction modifies the Nitric Oxide (NO) / cGMP signaling cascade.

Amplification and Physiological Consequence

The accumulated cGMP enhances the cellular signal generated by naturally released NO, meaning the drug's effect is contingent upon the physiological release of Nitric Oxide. This signal amplification triggers the relaxation of the smooth muscle cells in targeted vascular beds, particularly the corpus cavernosum and pulmonary arteries. The resulting smooth muscle relaxation causes vasodilation (vessel widening), which decreases local vascular resistance and contributes to increased blood flow and tissue perfusion.

How Sildenafil Orifarm is Used: Official Administration Guidelines

Sildenafil Orifarm film-coated tablets are for oral administration only. The official instructions for use, including dosage and frequency, are determined by the medical condition being addressed.

---

Official Dosing and Use Patterns

Indication	Dosing Schedule	Maximum Dose/Frequency
Erectile Dysfunction (ED)	Taken as needed, 30 minutes to 4 hours before sexual activity.	100 mg, once per day
Pulmonary Arterial Hypertension (PAH)	Scheduled dose of 20 mg, three times a day (TID).	The standard regimen is 20 mg TID (doses 4-6 hours apart)

---

Administration Requirements

Requirement	Instructions
With/Without Food	For ED, a high-fat meal may delay the onset of activity. For PAH, the tablets may be taken with or without food.
Preparation	Tablets should be swallowed whole. No further preparation is required.

---

Population-Specific Starting Doses

To manage potential increases in systemic exposure, a starting dose of 25 mg for the ED indication should be considered for older adults (65 years or older) and patients with severe renal or hepatic impairment (liver problems). Additionally, the maximum dose for ED must not exceed 25 mg within a 48-hour period when co-administered with potent CYP3A4 inhibitors, such as ritonavir.

These official instructions define the standardized, label-based approach for using the medicine and must be followed exactly as prescribed.

Research Evidence / Overview of Studies for Sildenafil Orifarm

---

Evidence for use in Erectile Dysfunction (ED)

Research exploring Sildenafil for Erectile Dysfunction (ED) is based on an large body of evidence derived primarily from numerous short-term, large-scale randomized controlled trials (RCTs). These pivotal studies were observed in broad populations of adult men with ED and compared the active compound against a placebo to observe patterns of change. The main focus of these trials was on outcomes reflecting daily functioning or activity level, specifically the patient's ability to attain and maintain an erection sufficient for sexual activity.

Evidence for use in Pulmonary Arterial Hypertension (PAH)

For the management of Pulmonary Arterial Hypertension (PAH), Sildenafil was studied for its impact on outcomes related to systemic or functional imbalance, particularly the change in functional capacity. The core evidence comes from pivotal, short-term randomized controlled trials comparing the compound to placebo, alongside long-term, open-label extension studies. Studies research examined functional capacity using objective measures like the 6-minute walk distance (6MWD).

Research Gaps and Areas of Uncertainty

While the research landscape provides significant context on short-term functional outcomes, certain areas require continued evaluation. Long-term effects are not fully established regarding overall prognosis in adult PAH patients, as dedicated trials to look at long-term mortality are complex and research is ongoing. Additionally, the compound was often evaluated in studies as part of combination regimens, which may complicate the isolation of its single effect. Research also explored the effects of chronic high doses in pediatric patients, leading to subsequent regulatory review and highlighting that subgroup findings are uncertain.

Key Studies & References

1. Guidelines for the Management of Erectile Dysfunction in Primary Care (Supports general clinical context and use in subgroups like diabetes/post-prostatectomy)

Common questions about Sildenafil Orifarm (FAQ)

---

Q: How quickly does Sildenafil Orifarm start working?

Official product information, based on studies, notes that the active ingredient, sildenafil, is absorbed rapidly into the body. For patients who were fasting, the time taken to reach the maximum concentration in the blood was approximately one hour.

---

Q: What is the expected duration of effect for Sildenafil Orifarm?

The terminal half-life of sildenafil, the active ingredient, is typically about 3 to 5 hours. This figure is used to describe how long the active substance remains present in the body.

---

Q: Can Sildenafil Orifarm be taken with food?

Official product labeling indicates that consuming Sildenafil with a high-fat meal may lead to a delay in the medicine's time to onset of activity. For other uses of the drug, the medicine may be taken with or without food.

---

Q: Does Sildenafil Orifarm interact with alcohol?

Regulatory information indicates that consuming heavy amounts of alcohol may increase the risk of experiencing hypotension (low blood pressure) when using sildenafil. This information is noted in regulatory documents regarding substance interaction.

---

Q: Does Sildenafil Orifarm work if the user has no sexual stimulation?

According to the official mechanism of action, Sildenafil works by amplifying a natural process that occurs during sexual stimulation. The pharmacological effect is contingent upon physiological release of nitric oxide during sexual stimulation.

---

Q: How long does Sildenafil Orifarm stay in the system?

The active ingredient, sildenafil, generally has a half-life of about four hours. The body eliminates the medicine and its major active breakdown product primarily through the faeces and, to a lesser extent, through the urine.

---

Q: Are generic versions of sildenafil as reliable as the original?

Generic medicines like Sildenafil Orifarm are approved by regulatory bodies only after clinical studies confirm they are bioequivalent to the original reference product. This ensures the generic delivers the same levels of the active substance to the bloodstream for consistent absorption.

---

Q: Is Sildenafil Orifarm the same drug as Viagra?

Sildenafil is the active ingredient in Sildenafil Orifarm, which is a generic medicine. The reference medicine originally authorised in the European Union containing sildenafil is Viagra.

---

Q: Is Sildenafil Orifarm available without a prescription?

Sildenafil Orifarm is generally classified as a prescription-only medicine (POM) in official product information. In some specific regions, certain lower-strength formulations of sildenafil may have a different dispensing classification.

---

Q: Can Sildenafil Orifarm be crushed or split?

Official instructions for use specify that the film-coated tablets should be swallowed whole. Regulatory information does not provide evidence or instructions to support altering the tablet by cutting or crushing it.

---

Q: Does taking Sildenafil Orifarm affect fertility?

Official studies examining the effect on semen and sperm function in healthy volunteers have indicated no significant differences compared to placebo.

---

Q: Can Sildenafil Orifarm cause headaches often?

Headache is listed in official safety documents as a Very Common adverse reaction, meaning it is one of the most frequently reported side effects. It is noted to potentially affect 1 in 10 patients or more.

---

Q: What should be done if a severe side effect occurs while using Sildenafil Orifarm?

Regulatory documents note that immediate medical assistance should be sought in the event of specific serious adverse events. These include an erection lasting longer than four hours (priapism), sudden loss of vision, or sudden decrease or loss of hearing.

---

Q: Does Sildenafil Orifarm have different uses other than for erectile dysfunction?

Yes, regulatory documents confirm that the active ingredient, sildenafil, is also indicated for the treatment of Pulmonary Arterial Hypertension (PAH) in adults and some pediatric patients.

---

Q: Are there any warnings about driving or operating machinery after taking Sildenafil Orifarm?

Since dizziness and visual disturbances have been reported in clinical trials, official safety notes state that patients should be aware of their response to the medicine before driving or operating machinery.

---

Q: Can Sildenafil Orifarm cause stomach upset or indigestion?

Dyspepsia (indigestion) is classified in official safety documents as a Common adverse reaction. This means that indigestion or stomach upset may be experienced by up to 1 in 10 patients.

---

Q: What is the role of nitric oxide in how Sildenafil Orifarm works?

The medicine's action is fundamentally linked to Nitric Oxide (NO). Sildenafil works by amplifying the effects of NO, which is naturally released in the body. This amplified signal is associated with the relaxation of smooth muscle and increased blood flow.

---

Q: What happens if Sildenafil Orifarm is taken too close to another dose?

For the treatment of erectile dysfunction, the official maximum recommended dosing frequency is once per day. For the PAH indication, if a dose is missed, patients are advised to take a dose as soon as possible, but not to take a double dose to compensate.

---

Q: Are there different strengths of Sildenafil Orifarm tablets?

Official product information, according to its composition, lists the availability of Sildenafil tablets in three common dosage strengths: 25 mg, 50 mg, and 100 mg.

How to Store and Dispose of Sildenafil Orifarm

Official regulatory information outlines specific requirements for storing and disposing of Sildenafil Orifarm tablets to ensure product integrity and public safety.

Mandatory Storage Conditions

Requirement	Official Statement
Temperature	Do not store above 30 C (where specified by the label).
Protection	Store in the original package to protect from moisture.
Access	Keep this medicine out of the sight and reach of children.

Sildenafil Orifarm must be kept in its original packaging to maintain protection from moisture and remain stable until the expiration date. It should not be used past the date labeled as EXP.

Official Disposal Rules

When disposing of expired or unused medicine, do not throw Sildenafil Orifarm away via wastewater or household waste. Proper pharmaceutical waste management requires consulting a pharmacist for guidance on disposal methods, such as utilizing a medicine take-back program, which helps protect the environment.